Table 2. Intra-assay and inter-assay accuracy and precision of metronidazole (MET), ceftriaxone (CEF), and hydroxymetronidazole (MET-OH) in plasma, and CEF in ultra-filtrate (CEF uf) at LLOQ, LOQ, MOQ and HOQ.
Intra-assay
(n=6) |
Compound | Nominal
concentration (µg/ mL) |
Mean estimated
concentration (µg/ mL) ±SD |
Precision
(CV %) |
Accuracy (%) |
---|---|---|---|---|---|
MET | 0.05 | 0.051 ± 2.0 | 3.9 | 101.9 | |
0.15 | 0.148 ± 7.7 | 7.8 | 98.7 | ||
20 | 20.44 ± 4.0 | 3.9 | 102.2 | ||
40 | 37.75 ± 5.6 | 5.9 | 94.4 | ||
CEF | 0.4 | 0.39 ± 2.5 | 3.2 | 97.5 | |
1.2 | 1.10 ± 1.5 | 1.7 | 91.7 | ||
120 | 112.02 ± 3.5 | 3.7 | 93.3 | ||
240 | 219.51 ± 6.8 | 7.5 | 91.5 | ||
MET-OH | 0.02 | 0.018 ± 1.7 | 2.6 | 90.0 | |
0.06 | 0.057 ± 4.7 | 4.9 | 95.0 | ||
12 | 11.43 ± 2.5 | 2.7 | 95.2 | ||
24 | 24.49 ± 8.6 | 8.4 | 102.0 | ||
CEF uf | 0.4 | 0.41 ± 5.5 | 5.3 | 100.9 | |
1.2 | 1.27 ± 5.5 | 5.2 | 105.8 | ||
120 | 112.32 ± 5.1 | 5.5 | 93.6 | ||
240 | 253.03 ± 8.2 | 7.8 | 105.4 | ||
Inter-assay
(n=18) |
MET | 0.05 | 0.051 ± 1.4 | 2.7 | 101.1 |
0.15 | 0.155 ± 5.6 | 5.4 | 103.3 | ||
20 | 20.59 ± 3.3 | 3.2 | 103.0 | ||
40 | 38.79 ± 5.6 | 5.8 | 97.0 | ||
CEF | 0.4 | 0.40 ± 2.7 | 2.9 | 100.0 | |
1.2 | 1.15 ± 3.8 | 3.9 | 95.8 | ||
120 | 114.54 ± 5.1 | 5.4 | 95.4 | ||
240 | 226.75 ± 5.2 | 5.5 | 94.5 | ||
MET-OH | 0.02 | 0.019 ± 1.2 | 2.3 | 95.0 | |
0.06 | 0.059 ± 5.2 | 5.3 | 98.3 | ||
12 | 12.01 ± 4.8 | 4.8 | 100.1 | ||
24 | 24.51 ± 4.7 | 4.6 | 102.1 | ||
CEF uf | 0.4 | 0.43 ± 5.8 | 7.4 | 107.2 | |
1.2 | 1.22 ± 8.3 | 8.1 | 101.6 | ||
120 | 115.32 ± 5.1 | 5.3 | 96.1 | ||
240 | 251.30 ± 6.2 | 5.9 | 104.6 |